FDAReview.org

The Covid-19 Ratchet Effect is Becoming Clearer, and More Concerning

Raymond March - July 2, 2021

Will the Biden Administration Let a Delta-Variant Covid-19 Crisis Go to Waste?

July 1, 2021

New Alzheimer’s Drug Approval Could Change the FDA’s Approval Process for the Better

June 10, 2021

Ecstasy Nears FDA Approval to Treat Severe Post-Traumatic Stress Disorder

June 3, 2021

What's New

AstraZeneca Vaccine Controversy Provides Another Example of Overly Cautious Government Reactions

Raymond March - March 26, 2021

Are We Witnessing the Beginning of the Covid-19 Ratchet Effect?

Raymond March - March 22, 2021

The FDA Should Grant Emergency Use Authorization for Alzheimer’s Drug

Raymond March - March 3, 2021

President Biden Faces Longstanding Challenge to Lower Insulin Prices. Will He...

Raymond March - February 10, 2021

Capping Insulin Copays Won’t Cure Insulin Price Woes

Raymond March - January 6, 2021

FDA Delays COVID Vaccine Review

Connor Norris - December 23, 2020

New COVID-19 Vaccines, Same Sluggish FDA

Raymond March - December 15, 2020

Public Health Bureaucracies Consolidate Power as Pandemic Continues

Raymond March - October 7, 2020

Economic Miscalculation and the Covid-19 Pandemic

Raymond March - October 1, 2020

FDA Approves Blood Plasma as Covid-19 Treatment

September 10, 2020

Promising Alzheimer’s Drug on FDA Fast Track

August 26, 2020

Is the Covid-19 Pandemic Spreading Affinity for Socialism? It Shouldn’t!

August 18, 2020

Trump Signs More Executive Orders as a Last-Ditch Effort to Lower...

August 4, 2020